Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

My previous session
Most popular
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Alere Inc : Award-Winning Healthcare Analytics Company, DiagnosisOne, Joins Alere Family

share with twitter share with LinkedIn share with facebook
share via e-mail
10/22/2012 | 03:05pm CEST

LOWELL, Mass., Oct. 22, 2012 /PRNewswire/ -- Clinical decision support (CDS) and analytics company, DiagnosisOne, recently joined the Alere family in July and is pleased to announce that it has been recognized by Black Book Rankings as the leading CDS vendor for Accountable Care Organizations (ACOs).

In August, Black Book Rankings reported client experience and customer satisfaction scores from organizations that participated in a survey to determine the top CDS solution vendor for ACOs. More than 2,800 CDS users were polled, the largest number to date, and 42 vendors were evaluated on the basis of 18 key performance indicators. DiagnosisOne received the highest scores and was identified as the leading CDS provider to ACOs.

"We are honored to be recognized as the leading CDS vendor for ACOs," said Mansoor Khan, Sc.D., CEO of DiagnosisOne. "We are also proud to join the Alere family and have access to broader resources that will advance our decision support and analytics solutions. DiagnosisOne remains focused on enabling customers to make the most informed, evidence-based decisions in real time, at the point of care and beyond."

The company provides end-to-end CDS capabilities that automatically make patient information from disparate systems accessible to a provider, along with a configurable collection of more than 25,000 actionable clinical alert observations and analytics. Its standards-based, turnkey solutions are fully configurable to each organization's specific needs with minimal effort, and they have been successfully deployed for hospital systems, multi-million member insurers, state and national governments, and leading electronic medical record vendors and systems integrators.

DiagnosisOne will continue to operate as an independent subsidiary of Alere, a leading provider of near-patient diagnostics and monitoring services, and its seasoned management team will remain intact. The company is currently seeking healthcare IT talent to support growing R&D efforts at its Lowell facility.

About DiagnosisOne

DiagnosisOne provides the healthcare industry with an unparalleled breadth and depth of analytics and clinical decision support solutions based on a single platform. Leveraging the world's largest library of evidence-based medical knowledge, DiagnosisOne's standards-based solutions integrate seamlessly with existing hospital and laboratory information systems to deliver actionable information that results in better patient care, reduced errors and better clinical outcomes. DiagnosisOne's customers include healthcare providers, payers, EMR companies, systems integrators and government entities, including the Centers for Disease Control (CDC), Massachusetts Department of Public Health and Blue Cross Blue Shield. Based in Lowell, Mass., DiagnosisOne was formed in 2003 by a team of physicians and healthcare IT professionals. In July 2012, DiagnosisOne joined Alere (NYSE: ALR), a leading provider of near-patient diagnostics and monitoring services, where it will operate as an independent subsidiary. For more information, visit www.DiagnosisOne.com.

Erin Zwirn
Schwartz MSL for DiagnosisOne

SOURCE DiagnosisOne

© PRNewswire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ALERE INC
2017ALERE : Receives FDA Clearance for Alere™ i Influenza A & B 2 Rapid Molecu..
2017ALERE : Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular..
2017ALERE : Announces the U.S. Department of Justice Closes Investigation
2017ALERE : Abbott Acquisition of Alere Set to Close on October 3, 2017
2017ALERE : Announces Agreement in Principle to Settle with the U.S. Department of J..
2017ALERE : Announces Settlement with SEC
2017ALERE : Announces Intent to Voluntarily Delist Series B Convertible Perpetual Pr..
2017ALERE INC. : Declares Cash Dividend on its Series B Convertible Perpetual Prefer..
2017ALERE INVESTIGATION INITIATED BY FOR : Kahn Swick & Foti, LLC Investigates the O..
2017ALERE INVESTIGATION INITIATED BY FOR : Kahn Swick & Foti, LLC Investigates the O..
More news
News from SeekingAlpha
2017TIME IS MONEY : Costly Deal Delays Put M&A Arbitrage Returns In The Spotlight 
2017FDA clears Alere's second-generation flu test 
2017Alere announces agreement in principle to settle with the U.S. Department of .. 
2017Abbott, Alere, and Approvals, Oh My 
2017Alere to divest two product lines to get FTC signoff on Abbott merger; shares..